Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-stage antiplasmodial activity

Eur J Med Chem. 2024 Nov 5:277:116782. doi: 10.1016/j.ejmech.2024.116782. Epub 2024 Aug 16.

Abstract

Dynamics of epigenetic modifications such as acetylation and deacetylation of histone proteins have been shown to be crucial for the life cycle development and survival of Plasmodium falciparum, the deadliest malaria parasite. In this study, we present a novel series of peptoid-based histone deacetylase (HDAC) inhibitors incorporating nitrogen-containing bicyclic heteroaryl residues as a new generation of antiplasmodial peptoid-based HDAC inhibitors. We synthesized the HDAC inhibitors by an efficient multicomponent protocol based on the Ugi four-component reaction. The subsequent screening of 16 compounds from our mini-library identified 6i as the most promising candidate, demonstrating potent activity against asexual blood-stage parasites (IC50Pf3D7 = 30 nM; IC50PfDd2 = 98 nM), low submicromolar activity against liver-stage parasites (IC50PbEEF = 0.25 μM), excellent microsomal stability (t1/2 > 60 min), and low cytotoxicity to HEK293 cells (IC50 = 136 μM).

Keywords: HDAC inhibitors; Histone deacetylase; Malaria; Multicomponent reaction; Peptoid.

MeSH terms

  • Antimalarials* / chemical synthesis
  • Antimalarials* / chemistry
  • Antimalarials* / pharmacology
  • Dose-Response Relationship, Drug
  • HEK293 Cells
  • Histone Deacetylase Inhibitors* / chemical synthesis
  • Histone Deacetylase Inhibitors* / chemistry
  • Histone Deacetylase Inhibitors* / pharmacology
  • Histone Deacetylases / metabolism
  • Humans
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Peptoids* / chemical synthesis
  • Peptoids* / chemistry
  • Peptoids* / pharmacology
  • Plasmodium falciparum* / drug effects
  • Plasmodium falciparum* / enzymology
  • Structure-Activity Relationship

Substances

  • Histone Deacetylase Inhibitors
  • Antimalarials
  • Peptoids
  • Histone Deacetylases